FDA to review risks of antidepressants in adultsBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7470.816-b (Published 07 October 2004) Cite this as: BMJ 2004;329:816
- Jeanne Lenzer
- New York
The US Food and Drug Administration (FDA) announced last week that it will examine whether antidepressants pose a similar risk of increased suicidal thoughts among adults as they do for children, by reanalysing data for adults.
“Our first priority with regard to the adult data is to finish our analysis of the adult completed …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial